ATE175209T1 - Allergene proteine aus ambrosia und verwendung davon - Google Patents

Allergene proteine aus ambrosia und verwendung davon

Info

Publication number
ATE175209T1
ATE175209T1 AT90905020T AT90905020T ATE175209T1 AT E175209 T1 ATE175209 T1 AT E175209T1 AT 90905020 T AT90905020 T AT 90905020T AT 90905020 T AT90905020 T AT 90905020T AT E175209 T1 ATE175209 T1 AT E175209T1
Authority
AT
Austria
Prior art keywords
amb
ambrosia
ragweed
proteins
allergic proteins
Prior art date
Application number
AT90905020T
Other languages
German (de)
English (en)
Inventor
Bruce Rogers
David G Klapper
Thorunn Rafnar
Mei-Chang Kuo
Original Assignee
Immulogic Pharma Corp
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23267582&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE175209(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immulogic Pharma Corp, Univ North Carolina filed Critical Immulogic Pharma Corp
Application granted granted Critical
Publication of ATE175209T1 publication Critical patent/ATE175209T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT90905020T 1989-03-17 1990-03-09 Allergene proteine aus ambrosia und verwendung davon ATE175209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32536589A 1989-03-17 1989-03-17

Publications (1)

Publication Number Publication Date
ATE175209T1 true ATE175209T1 (de) 1999-01-15

Family

ID=23267582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905020T ATE175209T1 (de) 1989-03-17 1990-03-09 Allergene proteine aus ambrosia und verwendung davon

Country Status (6)

Country Link
EP (2) EP0803511A1 (fr)
JP (1) JP3220451B2 (fr)
AT (1) ATE175209T1 (fr)
CA (1) CA2049921C (fr)
DE (1) DE69032868D1 (fr)
WO (1) WO1990011293A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776761A (en) * 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
US6555116B1 (en) * 1991-10-12 2003-04-29 Regents Of The University Of California Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
AU2926492A (en) * 1991-11-15 1993-06-15 University Of Melbourne, The Protein allergens of the species cynodon dactylon
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
CA2117779A1 (fr) * 1992-04-09 1993-10-28 Mei-Chang Kuo Determinants antigeniques du lymphocyte t des principaux allergenes d'ambroise artemisifolia
US6737406B1 (en) 1996-03-21 2004-05-18 Circassia, Ltd. Cryptic peptides and method for their identification
EP1958645A1 (fr) * 2007-02-13 2008-08-20 Biomay AG Peptides dérivés du allergène majeur de l'ambrosie (Ambrosia artemisiifolia) et leur utilisation
EP2331124A1 (fr) 2008-08-15 2011-06-15 Circassia Limited Peptide de l antigène des cellules t d allergène destiné à stimuler la production d il-10
ES2378870T5 (es) 2008-08-15 2016-02-03 Circassia Limited Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía
JP6062851B2 (ja) 2010-04-30 2017-01-18 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
EP2563390A4 (fr) 2010-04-30 2014-05-14 Allovate Llc Procédes et articles de prévention ou de réduction du risque de développement d'un système immunitaire hyperallergénique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338297A (en) 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction

Also Published As

Publication number Publication date
DE69032868D1 (de) 1999-02-11
EP0463059B1 (fr) 1998-12-30
EP0803511A1 (fr) 1997-10-29
CA2049921C (fr) 2004-06-15
WO1990011293A1 (fr) 1990-10-04
EP0463059A1 (fr) 1992-01-02
JP3220451B2 (ja) 2001-10-22
CA2049921A1 (fr) 1990-09-18
JPH04504119A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
Yunginger et al. Studies on Alternaria allergens: III. Isolation of a major allergenic fraction (Alt-i)
Yasueda et al. Comparative analysis of physicochemical and immunochemical properties of the two major allergens from Dermatophagoides pteronyssinus and the corresponding allergens from Dermatophagoides farinae
Sachs et al. Isolation and partial characterization of a major peanut allergen
Holen et al. Novel B and T cell epitopes of chicken ovomucoid (Gal d 1) induce T cell secretion of IL‐6, il‐13, and IFN‐γ
ATE175209T1 (de) Allergene proteine aus ambrosia und verwendung davon
DE69429723D1 (de) Stressproteine und ihre verwendung
LU91219I2 (fr) Omalizumab (anticorps humanisé recombinant anti-ige)
Elsayed et al. Evaluation of the allergenicity and antigenicity of bovine‐milk αs1‐casein using extensively purified synthetic peptides
DK228190A (da) Rajgraespollenallergen
Krilis et al. Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus: Part I. Demonstration of multiple allergens by immunochemical and biologic analyses
CA2121498A1 (fr) Peptides «recombitopes»
Løwenstein et al. Identification and Clinical Significance of Allergenic Molecules of Cat Origin: Part of the DAS 76* Study
Pajarón et al. Cross‐reactivity of Olea europaea with other Oleaceae species in allergic rhinitis and bronchial asthma
Michils et al. Early effect of ultrarush venom immunotherapy on the IgG antibody response
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE327252T1 (de) Verfahren zur identifizierung modifizierter rekombinanter graminaenpollen-allergene
WO1993021321A3 (fr) EPITOPES DE LYMPHOCYTES T DES PRINCIPAUX ALLERGENES D'$i(AMBROSIA ARTEMISIIFOLIA)
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
Kemeny et al. IgG and IgE antibodies after immunotherapy with bee and wasp venom
Ishizaka et al. Presence of reagin and γ1A-globulin in saliva
Florvaag et al. Comparative studies on tree pollen allergens: II. isolation of alder (alnus incana) pollen allergens: purification and some characteristics of the major allergen pi 4.78
JP2001521907A (ja) 天然アレルゲンの寛容原性断片
Ćirković et al. Physicochemical and immunologic characterization of low‐molecular‐weight allergoids of Dactylis glomerata pollen proteins
Ceska Characterization of Allergen Extracts by Dose-Response Studies and by Polyacrylamide Gel Isoelectrofocusing Using the Paper Disc Radioallergosorbent Test as the Assay Method: III. Horse Dandruff Allergen
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties